주요 콘텐츠로 건너뛰기

귀하의 브라우저가 완벽하게 지원되지 않습니다. 옵션이 있는 경우 최신 버전으로 업그레이드하거나 Mozilla Firefox, Microsoft Edge, Google Chrome 또는 Safari 14 이상을 사용하세요. 가능하지 않거나 지원이 필요한 경우 피드백을 보내주세요.

이 새로운 경험에 대한 귀하의 의견에 감사드립니다.의견을 말씀해 주세요 새 탭/창에서 열기

Elsevier
엘스비어와 함께 출판
Helping to Mitigate Risk in GenAI Tools for CDS
Whitepaper

Helping to Mitigate Risk in GenAI Tools for CDS

Elsevier uses a robust evaluation framework to assess ClinicalKey AI, its generative AI-powered clinical decision support tool, for efficacy and bias. Generative AI technologies hold immense potential to tackle challenges from boosting operational efficiencies to enhancing clinical decision support. However, their true value can only be realized when they are used safely, responsibly, and ethically. Read the white paper to gain insights into:

  • The importance of rigorous evaluation frameworks for generative AI in healthcare

  • Strategies to mitigate risks, including AI “hallucinations” and potential biases

  • The methodology used by Elsevier to evaluate the performance of ClinicalKey AI

Helping to Mitigate Risk in GenAI Tools for CDS

Helping to Mitigate Risk in GenAI Tools for CDS

Download here  새 탭/창에서 열기